Myriam Chalabi will present the long awaited 3-year DFS data for NICHE-2 at ESMO24

Myriam Chalabi shared her previous post on X, adding:

”Two years later, on September 15th at ESMO24, I will present the long awaited 3-year DFS (disease-free survival) data for NICHE-2. 

But that’s not all…exciting ctDNA (circulating tumor DNA) dynamics included. See you there!”

Quoting her post:

”About the smile: the standing ovation also meant that people saw what I knew: behind every one of these bars is a patient. I know every name and have seen almost everyone. I know their stories and their children. And I believe many are cured because of this.”

Source: Myriam Chalabi/X

Myriam Chalabi is a Gastrointestinal Oncologist and clinician scientist at the Netherlands Cancer Institute in Amsterdam. In 2022 she was named one of the 11 early career researchers to watch by Nature Medicine. In 2023 she was awarded the ESMO José Baselga Fellowship for Clinician Scientists.